Type 2 innate lymphoid cells control eosinophil homeostasis

Nature

Volumn 502, Issue 7470, 2013, Pages 245-248

  Nussbaum, Jesse C ^a   Van Dyken, Steven J ^a   Von Moltke, Jakob ^a   Cheng, Laurence E ^a   Mohapatra, Alexander ^b   Molofsky, Ari B ^a   Thornton, Emily E ^a   Krummel, Matthew F ^a   Chawla, Ajay ^a,b   Liang, Hong Erh ^a   Locksley, Richard M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BROXURIDINE; EOTAXIN; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 33; INTERLEUKIN 5; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ALLERGY; CELL ORGANELLE; HOMEOSTASIS; NUTRIENT UPTAKE; PEPTIDE; RECRUITMENT (POPULATION DYNAMICS); SERUM; SURVIVAL;

ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME ACTIVATION; EOSINOPHIL; HOMEOSTASIS; INTERNAL RIBOSOME ENTRY SITE; LAMINA PROPRIA; LOEFFLER PNEUMONIA; LYMPHOID CELL; MOUSE; NEWBORN; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TRANSLATION INITIATION;

ANIMALS; CELLS, CULTURED; CIRCADIAN RHYTHM; COLLAGEN; EOSINOPHILS; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; INTERLEUKIN-13; INTERLEUKIN-5; LUNG; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; NIPPOSTRONGYLUS; STRONGYLIDA INFECTIONS;

VERMES;

EID: 84885572626     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12526     Document Type: Article

References (30)

1. Rothenberg, M. E.& Hogan, S. P. The eosinophil. Annu. Rev. Immunol. 24, 147-174 (2006).
2. Takatsu, K.&Nakajima, H. IL-5 and eosinophilia. Curr. Opin.Immunol. 20, 288-294 (2008).
3. Pope, S. et al. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 108, 594-601 (2001).
4. Mishra, A., Hogan, S., Lee, J., Foster, P. & Rothenberg, M. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J. Clin. Invest. 103, 1719-1727 (1999).
5. Kopf, M. et al. IL-5-deficient mice have a developmental defect in CD51 B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4, 15-24 (1996).
6. Yoshida, T. et al. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Ra-deficient mice. Immunity 4, 483-494 (1996).
7. Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535-549 (2013).
8. Ikutani, M. et al. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J. Immunol. 188, 703-713 (2012).
9. Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647-675 (2012).
10. Price, A. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl Acad. Sci. USA 107, 11489-11494 (2010).
11. Liang, H. E. et al. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nature Immunol. 13, 58-66 (2012).
12. Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
13. Moro, K. et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit1Sca-11 lymphoid cells. Nature 463, 540-544 (2010).
14. Carlens, J. et al. Common c-chain-dependent signals confer selective survival of eosinophils in the murine small intestine. J. Immunol. 183, 5600-5607 (2009).
15. Halberg, F., Visscher, M. & Bittner, J. Eosinophil rhythm in mice: range of occurrence; effects of illumination, feeding, and adrenalectomy. Am. J. Physiol. 174, 109-122 (1953).
16. Pauly, J. et al. Meal timing dominates the lighting regimen as a synchronizer of the eosinophil rhythm in mice. Acta Anat. 93, 60-68 (1975).
17. Lelievre, V. et al. Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease. Peptides 28, 1688-1699 (2007).
18. Maywood, E. S. et al. Analysis of core circadian feedback loop in suprachiasmatic nucleus of mCry1-luc transgenic reporter mouse. Proc. Natl Acad. Sci. USA 110, 9547-9552 (2013).
19. Harmar, A. J. et al. The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 109, 497-508 (2002).
20. Colwell, C. S. et al. Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R939-R949 (2003).
21. Sheward,W. J. et al. Entrainment to feeding but not to light: circadian phenotype of VPAC2 receptor-null mice. J. Neurosci. 27, 4351-4358 (2007).
22. Voice, J. et al. c-Maf and JunBmediation of Th2 differentiation induced by the type 2Gprotein-coupled receptor (VPAC2) for vasoactive intestinal peptide. J. Immunol. 172, 7289-7296 (2004).
23. Samarasinghe, A. E., Hoselton, S. A. & Schuh, J. M. The absence of the VPAC2 receptor does not protect mice from Aspergillus induced allergic asthma. Peptides 31, 1068-1075 (2010).
24. Tsutsumi, M. et al. A potent and highly selective VPAC2 agonist enhances glucoseinduced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes 51, 1453-1460 (2002).
25. Dickson, L. & Finlayson, K. VPAC and PAC receptors: From ligands to function. Pharmacol. Ther. 121, 294-316 (2009).
26. Domarus, A. v. Die bedeutung der kammerzahlung der eosinophilen fur die klinik. Dtsch. Arch. Klin. Med. 171, 333-358 (1931).
27. Mjösberg, J. M. et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nature Immunol. 12, 1055-1062 (2011).
28. Sullivan, B. M. et al. Genetic analysis of basophil function in vivo. Nature Immunol. 12, 527-535 (2011).
29. Thornton, E. E. et al. Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung. J. Exp. Med. 209, 1183-1199 (2012).
30. Vomhof-DeKrey, E. E. et al. Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis. Peptides 32, 2058-2066 (2011).